Polymer solar cells, known for their light weight and flexibility, are ideal for wearable devices. Yet, their broader use is hindered by the toxic halogenated solvents required in their production. These solvents pose environmental and health risks, limiting the appeal of these solar cells. Alternative solvents, which are less toxic, unfortunately, lack the same solubility, necessitating higher temperatures and prolonged processing times.
This inefficiency further impedes the adoption of polymer solar cells. Developing a method to eliminate the need for halogenated solvents could significantly enhance the efficiency of organic solar cells, making them more suitable for wearable technology.
In a recently published paper, researchers outline how improving molecular interactions between the polymer donors and the small molecule acceptors using side-chain engineering can reduce the need for halogenated processing solvents.
The paper was recently published in Nano Research Energy.
"Blend morphology of polymer donors and small molecule acceptors are highly affected by their molecular interactions, which can be determined by interfacial energies between the donor and acceptor materials. When their surface tension values are similar, the interfacial energies and molecular interactions between the donors and the acceptors are expected to be more favorable," said Yun-Hi Kim, a professor at Gyeongsang National University in Jinju, Republic of Korea. "To enhance the hydrophilicity of the polymer donors and reduce molecular demixing, side-chain engineering can be a plausible avenue."
The Role of Side-Chain Engineering
Side-chain engineering is when a chemical group, called a side chain, is added to the main chain of a molecule. The chemical groups in the side chain affect the properties of the larger molecule. Researchers theorized that adding oligoethylene glycol (OEG)-based side chains would improve the hydrophilicity of the polymer donors thanks to the oxygen atoms in the side chains. A molecule with hydrophilicity is attracted to water.
A blend of hydrocarbon and hydrophilic oligoethylene glycol (2EG) performed better than the standard solvent when used in PSC creation, based on overall performance and thermal stability. Credit: Nano Research Energy, Tsinghua University Press
Differences in the hydrophilicity of the polymer donors and the small molecule acceptors can impact how they interact. With increased hydrophilicity of the polymer donors and improved interactions between them and the small molecule acceptors, non-halogenated processing solvents can be used without sacrificing the performance of the solar cell. In fact, polymer solar cells made with OEG-based side chains attached to a benzodithiophene-based polymer donor had a higher power conversion efficiency at 17.7% compared to 15.6%.
Enhanced Efficiency and Stability
In order to compare results, researchers designed benzodithiophene-based polymer donors with either an OEG side chain, hydrocarbon side chains, or side chains that were 50% hydrocarbon and 50% OEG. "This elucidated the effect of side-chain engineering on blend morphology and performance of non-halogenated solvent-processed polymer solar cells," said Kim. "Our findings demonstrate that polymers with hydrophilic OEG side chains can enhance the miscibility with small molecule acceptors and improve power conversion efficiency and device stability of polymer solar cells during non-halogenated processing."
In addition to improved power conversion efficiency, the polymer solar cells with the OEG-based side chains had enhanced thermal stability. Thermal stability is essential for scaling polymer solar cells, so researchers heated them to 120 degrees Celsius and then compared the power conversion efficiency. After 120 hours of heating, the polymers with the hydrocarbon side chains had only 60% of their initial power conversion efficiency and had irregularities on their surface, while the blend of hydrocarbon and OEG retained 84% of their initial power conversion efficiency.
"Our results can provide a useful guideline for designing polymer donors that produce efficient and stable polymer solar cells using non-halogenated solvent processing," said Kim.
Reference: "Polymer donors with hydrophilic side-chains enabling efficient and thermally-stable polymer solar cells by non-halogenated solvent processing" by Soodeok Seo, Jun-Young Park, Jin Su Park, Seungjin Lee, Do-Yeong Choi, Yun-Hi Kim and Bumjoon J. Kim, 24 July 2023, Nano Research Energy.
DOI: 10.26599/NRE.2023.9120088
Other contributors include Soodeok Seo, Jin Su Park, and Bumjoon J. Kim of the Korea Advanced Institute of Science and Technology; Jun-Young Park and Do-Yeong Choi of Gyeongsang National University; and Seungjin Lee of the Korea Research Institute of Chemical Technology.
The Korea Institute of Energy Evaluation and Planning and the Korean National Research Foundation funded this research.
News
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
Natural Compound in Broccoli Could Help Treat a Rare, Incurable Neurological Disease
Swinburne researchers have discovered how broccoli could help treat an extremely rare and incurable disease that affects only about 200 Australians. A naturally occurring compound in broccoli is being investigated as a possible treatment [...]
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]
Ebola kills 2,300 in three months with no vaccine available for Congo’s deadliest ever outbreak
It’s Congo’s 17th outbreak, with a toll that has eclipsed that of the country’s 2018-2020 outbreak when 2,299 deaths out of 3,481 cases were recorded. The latest data shows 101 new cases and 33 [...]
